The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...
11hon MSN
You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong ...
Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...
Against a backdrop of rising U.S.-China geopolitical tensions, there are signs of growing dealmaking activity between Western ...
Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...
It has also been highly critical of parallel trade, and has been one of those militating for a pharmaceutical repackaging ban in the EU. Despite this political clout, the company also tried to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback